Infinity Pharmaceuticals Inc. (INFI) stock plunged following the investor event happening today
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) stock declined by 2.52% at the last close whereas the INFI stock price declined by 0.43% today. Infinity Pharmaceuticals is a medical biotechnology business working on eganelisib (IPI-549) which is an oral immuno-oncology macrophage reprogramming therapy that has been shown to target a core biologic mechanism of immune suppression in […]
